Radboudumc and partners

Investment in ARNE helps neonatologists make better decisions when treating newborn babies

ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child.

Radboudumc receives grant from Nationaal Groeifonds Investments in Biotech Booster, Oncode-PACT and PharmaNL

The Nationaal Groeifonds awards large grants to three consortia of which the Radboudumc is a member. Oncode-PACT, PharmaNL and Biotech Booster will receive amounts ranging from 80 to 325 million euros.

Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm

Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides.

Cell4Pharma enters into distribution agreement and strategic partnership with MatTek

MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new in vitro kidney model.

Continuous monitoring of patients' most important vital signs improves patient safety 32% fewer unplanned ICU admissions thanks to a wrist monitor